Natixis Advisors
HALO icon

Natixis Advisors’s Halozyme HALO Stock Holding History

Natixis Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.63M Sell
97,536
-8,769
-8% -$598K 0.01% 807
2026
Q1 		$6.87M Buy
106,305
+7,009
+7% +$494K 0.01% 762
2025
Q4 		$6.68M Sell
99,296
-15,032
-13% -$1.01M 0.01% 745
2025
Q3 		$8.38M Sell
114,328
-26,414
-19% -$1.75M 0.01% 701
2025
Q2 		$7.32M Sell
140,742
-3,003
-2% -$171K 0.01% 726
2025
Q1 		$9.17M Buy
143,745
+24,311
+20% +$1.41M 0.02% 672
2024
Q4 		$5.71M Sell
119,434
-2,126
-2% -$109K 0.01% 788
2024
Q3 		$6.96M Buy
121,560
+56,461
+87% +$3.24M 0.01% 745
2024
Q2 		$3.41M Buy
65,099
+11,763
+22% +$516K 0.01% 887
2024
Q1 		$2.17M Buy
53,336
+15,012
+39% +$563K 0.01% 1013
2023
Q4 		$1.42M Sell
38,324
-6,496
-14% -$245K ﹤0.01% 1105
2023
Q3 		$1.71M Buy
44,820
+1,790
+4% +$73.3K 0.01% 1024
2023
Q2 		$1.55M Buy
43,030
+13,655
+46% +$466K ﹤0.01% 1045
2023
Q1 		$1.12M Sell
29,375
-21,414
-42% -$1M ﹤0.01% 1113
2022
Q4 		$2.89M Buy
50,789
+8,131
+19% +$416K 0.01% 836
2022
Q3 		$1.69M Buy
42,658
+4,818
+13% +$213K 0.01% 943
2022
Q2 		$1.67M Buy
37,840
+7,621
+25% +$330K 0.01% 964
2022
Q1 		$1.21M Buy
30,219
+3,928
+15% +$140K ﹤0.01% 1084
2021
Q4 		$1.06M Sell
26,291
-3,629
-12% -$135K ﹤0.01% 1112
2021
Q3 		$1.22M Sell
29,920
-3,773
-11% -$158K 0.01% 1050
2021
Q2 		$1.53M Buy
33,693
+1,989
+6% +$88K 0.01% 997
2021
Q1 		$1.32M Buy
31,704
+8,312
+36% +$379K 0.01% 989
2020
Q4 		$999K Sell
23,392
-28,925
-55% -$1.04M 0.01% 1015
2020
Q3 		$1.38M Buy
52,317
+130
+0.2% +$3.62K 0.01% 887
2020
Q2 		$1.4M Buy
+52,187
New +$1.18M 0.01% 890

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Natixis Advisors's HALO Position: Q2 2026 in Review

Natixis Advisors reduced its Halozyme (HALO) stake by 8.2% in Q2 2026, selling an estimated $598K and leaving 97,536 shares worth $7.63M. The position accounts for 0.01% of the portfolio, ranked #807.

Natixis Advisors first reported a position in HALO in Q2 2020 and has held it in 25 quarters since. The position peaked at $9.17M in Q1 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Natixis Advisors held 97,536 shares of Halozyme worth $7.63M as of Q2 2026.
  • Natixis Advisors sold 8,769 Halozyme shares in Q2 2026, an estimated $598K.
  • Halozyme made up 0.01% of Natixis Advisors's portfolio in Q2 2026, its #807 holding.
  • Natixis Advisors first reported a position in Halozyme in Q2 2020 and has held it in 25 quarters since.
  • Natixis Advisors's Halozyme position peaked at $9.17M in Q1 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.